Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-week neoadjuvant anastrozole window trial in postmenopausal ER+ breast cancer
2018-000112-21Phase 3Terminated
- Sponsor
- Heidelberg University
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of anastrozole in breast cancer, sponsored by Heidelberg University. Primary endpoint: kynurenine concentration. Started Jun 2018; status: terminated.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2018-000112-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000112-21.